David Happel - President & CEO, Director at Sagimet Biosciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SGMT on Nasdaq
All Insider Reports
All Insider Reports

David Happel - trading volume in the past year for Sagimet Biosciences Inc.

Holdings reported by David Happel for Sagimet Biosciences Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A Common Stock 639K $3.37M $5.27 Mar 26, 2024 Direct
Stock Option (Right to Buy) 1.01M Jul 18, 2023 Direct Series A Common Stock

Transactions reported by David Happel for Sagimet Biosciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.